Sponsor: Surf Therapeutics · Phase: PHASE2 · Area: IMMUNOLOGY · Target Enrollment: 40 pts
Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.
Download $49 NCT07293871 Rescue Dossier →